INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 500 | $20.64 | 83,851 |
Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 1,200 | $20.65 | 82,651 |
Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 1,400 | $20.66 | 81,251 |
Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $20.67 | 81,051 |
Dec 14, 2010 |
Director, EVP CSO & Pres Regn Res Labs
|
Director, EVP CSO & Pres Regn Res Labs | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 250,000 | -- | 870,375 |
Feb 08, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 5 | Other acquisition or disposition | -- | -- | 323,777 |
Feb 08, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 5 | Other acquisition or disposition | -- | -- | 176,223 |
Feb 08, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 5 | Other acquisition or disposition | -- | -- | 5,702 |
Feb 08, 2018 |
Director, President and CSO
|
Director, President and CSO | Form 5 | Other acquisition or disposition | -- | -- | 64,058 |
Aug 17, 2017 |
Director, President and CSO
|
Director, President and CSO | Form 5 | Acquisition or disposition by will or the laws of descent and distribution | 847 | -- | 423,609 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.